Zebrafish Ephrin-B2 Alexa Fluor™ Plus 594-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # AF1088AFP594
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Applications
Western Blot
Formulation, Preparation, and Storage
Formulation
Shipping
Stability & Storage
Background: Ephrin-B2
Ephrin-B2 is a member of the ephrin ligand family, which binds members of the Eph receptor family. All ligands share a conserved extracellular sequence, which most likely corresponds to the receptor-binding domain. This conserved sequence consists of approximately 125 amino acids and includes four invariant cysteines. The B-class ligands are transmembrane proteins, which can be tyrosine phosphorylated upon receptor ligation. The cytoplasmic domains are approximately 80 amino acids long and are highly conserved, especially the last 33 amino acids. Several signaling molecules have been shown to interact with the cytoplasmic region, although specific signaling roles have yet to be elucidated. Ephrin-B2 has been shown to bind EphA4, EphB1, EphB2, EphB3, and EphB4. Only membrane-bound or Fc-clustered ligands are capable of activating the receptor in vitro. While soluble monomeric ligands bind the receptor, they do not induce receptor autophosphorylation and activation. In vivo, the ligands and receptors display reciprocal expression, indicating a general function for Eph/ephrin signaling in defining spatial boundaries in the embryo. Ephrin-B2 has been shown to play a role in a variety of developmental processes, including arterial-venous differentiation, neural crest cell migration, and axon guidance. Zebrafish Ephrin-B2 shares 66% amino acid identity with mouse Ephrin-B2. In zebrafish embryos, EphA4 and Ephrin-B2 are expressed sequentially along the anteroposterior axis of the embryo within the presomitic and somitic mesoderm. It has been shown that interference with Eph signaling leads to loss or incorrect formation of somite boundaries and disruption of myogenic differentiation.
References
- Eph Nomenclature Committee (1997) Cell [letter] 90(3):403.
- Flanagan, J.G. and P. Vanderhaeghen (1998) Annu. Rev. Neurosci. 21:309.
- Pasquale, E.B. (1997) Curr. Opin. Cell Biol. 9(5):608.
- Durbin, L. et al. Genes & Dev. (1998) 12:3096.
- Adams, et al. Genes & Dev. (1999) 13:295.
Alternate Names
Gene Symbol
UniProt
Additional Ephrin-B2 Products
Product Specific Notices
This product is provided under an intellectual property license from Life Technologies Corporation. The transfer of this product is conditioned on the buyer using the purchased product solely in research conducted by the buyer, excluding contract research or any fee for service research, and the buyer must not (1) use this product or its components for (a) diagnostic, therapeutic or prophylactic purposes; (b) testing, analysis or screening services, or information in return for compensation on a per-test basis; or (c) manufacturing or quality assurance or quality control, and/or (2) sell or transfer this product or its components for resale, whether or not resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@thermofisher.com.
For research use only